Researcher
Sare Verstockt
- Disciplines:Endocrinology and metabolic diseases, Gastro-enterology and hepatology, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Oct 2019 → Today - Laboratory for Complex Genetics (Division)
Member
From1 Oct 2015 → 30 Sep 2019
Projects
1 - 3 of 3
- Characterization of triggers of post-operative recurrence in Crohn’s disease in both the external and luminal side of the intestineFrom1 Jan 2023 → TodayFunding: FWO research project
- Lipidomic, microbial and functional characterization of triggers of post-operative recurrence in Crohn’s diseaseFrom1 Oct 2021 → TodayFunding: FWO junior postdoctoral fellowship
- Molecular profiling of early events in the pathogenesis of inflammatory bowel diseaseFrom1 Oct 2015 → 9 Oct 2019Funding: BOF - doctoral mandates, BOF - Doctoral projects
Publications
31 - 40 of 44
- SEROLOGICAL MARKERS DEFINE NEWLY DIAGNOSED CROHN'S DISEASE AND ULCERATIVE COLITIS BASED ON THE AGE AT DIAGNOSIS(2018)
Authors: Sare Verstockt, Bram Verstockt, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Isabelle Cleynen
Pages: S392 - S392 - TRANSCRIPTOMIC PROFILE OF INFLAMED COLONIC BIOPSIES FROM NEWLY DIAGNOSED CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS DEPEND ON THE AGE AT DIAGNOSIS(2018)
Authors: Sare Verstockt, Bram Verstockt, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Isabelle Cleynen
Pages: S1026 - S1026 - SERUM PROTEOMIC PROFILING REVEALS CHANGES IN INFLAMMATORY PROFILES WITH CONSECUTIVE BIOLOGICAL THERAPIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE(2018)
Authors: Sare Verstockt, Bram Verstockt, Gert Van Assche, Marc Ferrante, Kathleen Machiels, Séverine Vermeire
Pages: S1023 - S1023 - COLONIC INFLAMMATION DETERMINES ILEAL GENE EXPRESSION CHANGES IN ULCERATIVE COLITIS(2018)
Authors: Sare Verstockt, Marc Ferrante, Gert Van Assche, Séverine Vermeire, Isabelle Cleynen
Pages: S1025 - S1026 - DISCRIMINATION OF ENDOSCOPIC POSTOPERATIVE RECURRENCE IN PATIENTS WITH CROHN'S DISEASE USING SEROLOGICAL INFLAMMATORY MARKERS(2018)
Authors: Kathleen Machiels, Sare Verstockt, Bram Verstockt, Gert Van Assche, Albert Wolthuis, André D'Hoore, Marc Ferrante, Séverine Vermeire
Pages: S586 - S587 - PREDICTIVE SEROLOGICAL MARKERS OF RESPONSE TO USTEKINUMAB IN PATIENTS WITH REFRACTORY CROHN'S PROVIDE NOVEL INSIGHTS IN THE MECHANISM OF ACTION(2018)
Authors: Bram Verstockt, Séverine Vermeire, Sare Verstockt, Brecht Creyns, Nooshin Ardeshir Davani, Christine Breynaert, Gert Van Assche, Marc Ferrante
Pages: S187 - S187 - Serum markers predict outcome to ustekinumab in patients with refractory Crohn's disease and provide insides in the mechanism of action(2018)
Authors: Bram Verstockt, Séverine Vermeire, Sare Verstockt, Brecht Creyns, N Ardeshir Davani, Christine Breynaert, Gert Van Assche, G Van Assche, Marc Ferrante
Pages: S110 - S110 - Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease(2017)
Authors: Maaike Vancamelbeke, Tim Vanuytsel, Sare Verstockt, Marc Ferrante, Gert Van Assche, Paul Rutgeerts, Frans Schuit, Séverine Vermeire, Ingrid Arijs, Isabelle Cleynen
Pages: 1718 - 1729 - Dysregulated gene and miRNA expression in different stages of Crohn’s disease(2017)
Authors: Isabelle Cleynen, Sare Verstockt, Gert De Hertogh, Jan Van der Goten, Maaike Vancamelbeke, Bram Verstockt, Kathleen Machiels, Leentje Van Lommel, Frans Schuit, Paul Rutgeerts, et al.
- INCREASED BASELINE TNF-DRIVEN PATHWAYS OBSERVED IN PATIENTS WITH CROHN'S DISEASE NOT RESPONDING TO INFLIXIMAB(2017)
Authors: Bram Verstockt, Ingrid Arijs, Magali de Bruyn, Sare Verstockt, Gert Van Assche, Christine Breynaert, Séverine Vermeire, Marc Ferrante
Pages: S767 - S767